Shareholder suit challenges Dell buyout plan

Feb 06, 2013 by Randall Chase

A lawsuit challenging plans to take troubled personal computer maker Dell Inc. private is being filed in Delaware.

The lawsuit filed Wednesday claims that company founder and a group led by investment firm Silver Lake are trying to buy the Round Rock, Texas-based computer maker on the cheap for $24.4 billion, or $13.65 per share.

The lawsuit was filed one day after the management-led leveraged buyout was announced.

It accuses Michael Dell and company directors of breaching their fiduciary duties by failing to maximize shareholder value and selling the company at an inadequate price at the expense of minority shareholders.

Anticipating resistance to the deal from stockholders, Dell's board has said other potential buyers will have 45 days for to submit higher bids.

Explore further: Dell near $23 bn mega-deal to take company private, report says

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

New Zealand emerges as guinea pig for global tech firms

7 hours ago

When Google chose New Zealand to unveil secret plans for a balloon-driven wi-fi network last weekend, it cemented the country's reputation as a test bed for global tech companies looking to trial their latest innovations, ...

User comments : 0

More news stories

Multiview 3-D photography made simple

Computational photography is the use of clever light-gathering tricks and sophisticated algorithms to extract more information from the visual environment than traditional cameras can.

EUROnu project recommends building Neutrino Factory

(Phys.org) —The European Union's Seventh Framework Programme, EUROnu, has submitted its findings to a panel at CERN. Charged with choosing a project to study the nature of matter and antimatter, the project ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.